GLOMERULONEPHRITIS
Clinical trials for GLOMERULONEPHRITIS explained in plain language.
Never miss a new study
Get alerted when new GLOMERULONEPHRITIS trials appear
Sign up with your email to follow new studies for GLOMERULONEPHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug zigakibart tested for Long-Term kidney protection
Disease control Recruiting nowThis study looks at the long-term safety of a drug called zigakibart for people with IgA nephropathy, a kidney disease. It is for adults who have already finished another zigakibart study. Researchers will monitor side effects and check kidney function over 96 weeks.
Matched conditions: GLOMERULONEPHRITIS
Phase: PHASE3 • Sponsor: Novartis Pharmaceuticals • Aim: Disease control
Last updated May 26, 2026 02:48 UTC
-
Immune cell therapy takes on lupus kidney disease
Disease control Recruiting nowThis study tests a new treatment called NKX019, which uses specially engineered immune cells (CAR NK cells) to target and calm overactive immune cells that attack the kidneys. It is for people with active lupus nephritis or primary membranous nephropathy who have not responded to…
Matched conditions: GLOMERULONEPHRITIS
Phase: PHASE1, PHASE2 • Sponsor: Nkarta, Inc. • Aim: Disease control
Last updated May 18, 2026 12:12 UTC